$3.25 Billion is the total value of Nantahala Capital Management's 106 reported holdings in Q4 2019. The portfolio turnover from Q3 2019 to Q4 2019 was 20.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRput | $720,666,000 | +76.4% | 4,350,000 | +61.1% | 22.20% | +46.6% |
| XBI | Buy | SPDR SERIES TRUSTput | $213,998,000 | +211.8% | 2,250,000 | +150.0% | 6.59% | +159.2% |
| SGMS | SCIENTIFIC GAMES CORPcall | $160,423,000 | +31.6% | 5,990,400 | 0.0% | 4.94% | +9.4% | |
| CVNA | Sell | CARVANA COcall | $142,742,000 | +39.3% | 1,550,700 | -0.1% | 4.40% | +15.8% |
| ARQL | Sell | ARQULE INC | $130,625,000 | +81.1% | 6,544,347 | -34.9% | 4.02% | +50.5% |
| THC | Sell | TENET HEALTHCARE CORPcall | $98,840,000 | +42.8% | 2,599,000 | -16.9% | 3.04% | +18.7% |
| QURE | Sell | UNIQURE NV | $95,440,000 | +23.2% | 1,331,838 | -32.4% | 2.94% | +2.4% |
| CDXS | CODEXIS INC | $85,762,000 | +16.6% | 5,363,484 | 0.0% | 2.64% | -3.1% | |
| VAC | MARRIOTT VACTINS WORLDWID CO | $84,758,000 | +24.3% | 658,262 | 0.0% | 2.61% | +3.3% | |
| QURE | Sell | UNIQURE NVcall | $82,768,000 | +7.0% | 1,155,000 | -41.2% | 2.55% | -11.0% |
| CASH | META FINL GROUP INC | $65,708,000 | +12.0% | 1,799,727 | 0.0% | 2.02% | -6.9% | |
| DXPE | DXP ENTERPRISES INC NEW | $63,793,000 | +14.7% | 1,602,433 | 0.0% | 1.96% | -4.7% | |
| QADA | QAD INCcl a | $63,699,000 | +10.3% | 1,250,722 | 0.0% | 1.96% | -8.3% | |
| FCAU | Sell | FIAT CHRYSLER AUTOMOBILES Ncall | $61,257,000 | -18.7% | 4,170,000 | -28.4% | 1.89% | -32.4% |
| RH | Sell | RHcall | $57,538,000 | +6.9% | 269,500 | -14.4% | 1.77% | -11.1% |
| HCA | HCA HEALTHCARE INCput | $47,299,000 | +22.7% | 320,000 | 0.0% | 1.46% | +2.0% | |
| GDEN | GOLDEN ENTMT INC | $47,083,000 | +44.6% | 2,449,713 | 0.0% | 1.45% | +20.2% | |
| CZR | CAESARS ENTMT CORPcall | $45,302,000 | +16.6% | 3,331,000 | 0.0% | 1.40% | -3.0% | |
| LXFR | Sell | LUXFER HOLDINGS PLC | $45,026,000 | +11.1% | 2,432,531 | -6.5% | 1.39% | -7.7% |
| FRG | New | FRANCHISE GROUP INC | $43,687,000 | – | 1,910,247 | +100.0% | 1.35% | – |
| AKBA | Buy | AKEBIA THERAPEUTICS INC | $42,579,000 | +87.6% | 6,737,120 | +16.4% | 1.31% | +56.0% |
| THC | Sell | TENET HEALTHCARE CORP | $41,906,000 | -5.4% | 1,101,914 | -45.0% | 1.29% | -21.3% |
| SGMS | Sell | SCIENTIFIC GAMES CORP | $38,228,000 | +30.7% | 1,427,465 | -0.7% | 1.18% | +8.7% |
| EXAS | Sell | EXACT SCIENCES CORPput | $37,732,000 | -69.6% | 408,000 | -70.3% | 1.16% | -74.8% |
| DLB | DOLBY LABORATORIES INC | $35,892,000 | +6.4% | 521,693 | 0.0% | 1.11% | -11.5% | |
| TBBK | Sell | BANCORP INC DEL | $34,811,000 | +29.5% | 2,683,938 | -1.1% | 1.07% | +7.6% |
| Buy | APTOSE BIOSCIENCES INC | $34,325,000 | +285.8% | 6,053,830 | +41.9% | 1.06% | +220.3% | |
| W | Buy | WAYFAIR INCcl a | $32,793,000 | -3.4% | 362,870 | +19.8% | 1.01% | -19.7% |
| BDSI | BIODELIVERY SCIENCES INTL IN | $30,628,000 | +50.1% | 4,846,167 | 0.0% | 0.94% | +24.9% | |
| IMXI | Buy | INTERNATIONAL MNY EXPRESS IN | $30,251,000 | -2.2% | 2,512,521 | +11.6% | 0.93% | -18.7% |
| WRLD | Buy | WORLD ACCEP CORP DEL | $27,367,000 | -21.0% | 316,753 | +16.6% | 0.84% | -34.3% |
| W | New | WAYFAIR INCcall | $27,111,000 | – | 300,000 | +100.0% | 0.84% | – |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $24,117,000 | +49.7% | 871,922 | +2.3% | 0.74% | +24.5% |
| ONDK | Sell | ON DECK CAP INC | $23,485,000 | +9.5% | 5,672,644 | -11.2% | 0.72% | -9.1% |
| CRHM | CRH MEDICAL CORP | $22,636,000 | +12.7% | 6,534,155 | 0.0% | 0.70% | -6.3% | |
| CUE | Buy | CUE BIOPHARMA INC | $22,303,000 | +92.0% | 1,404,941 | +1.9% | 0.69% | +59.4% |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $21,791,000 | -0.7% | 2,852,260 | 0.0% | 0.67% | -17.5% | |
| HTZGQ | HERTZ GLOBAL HLDGS INCcall | $21,132,000 | +13.8% | 1,341,700 | 0.0% | 0.65% | -5.4% | |
| PAR | PAR TECHNOLOGY CORP | $19,305,000 | +29.3% | 628,017 | 0.0% | 0.60% | +7.6% | |
| PRTY | Buy | PARTY CITY HOLDCO INC | $17,938,000 | -47.9% | 7,665,774 | +27.2% | 0.55% | -56.6% |
| DHX | Sell | DHI GROUP INC | $14,567,000 | -24.3% | 4,839,595 | -3.2% | 0.45% | -37.0% |
| ENT | Buy | GLOBAL EAGLE ENTMT INC | $14,516,000 | -30.3% | 29,031,542 | +0.7% | 0.45% | -42.1% |
| MED | Buy | MEDIFAST INC | $14,245,000 | +13.2% | 130,000 | +7.1% | 0.44% | -5.8% |
| Sell | FALCON MINERALS CORP | $13,726,000 | +18.3% | 1,944,144 | -3.7% | 0.42% | -1.6% | |
| JYNT | JOINT CORP | $13,701,000 | -13.3% | 848,881 | 0.0% | 0.42% | -27.9% | |
| SLNO | New | SOLENO THERAPEUTICS INC | $12,577,000 | – | 4,277,923 | +100.0% | 0.39% | – |
| CCXI | CHEMOCENTRYX INCcall | $11,865,000 | +483.3% | 300,000 | 0.0% | 0.37% | +388.0% | |
| HTZGQ | HERTZ GLOBAL HLDGS INC | $11,844,000 | +13.8% | 751,995 | 0.0% | 0.36% | -5.4% | |
| SCPL | Buy | SCIPLAY CORPcl a | $11,503,000 | +330.0% | 935,975 | +274.4% | 0.35% | +257.6% |
| SIC | Buy | SELECT INTERIOR CONCEPTS INCcl a | $9,590,000 | +13.2% | 1,066,761 | +63.2% | 0.30% | -6.1% |
| VMD | VIEMED HEALTHCARE INC | $9,385,000 | -9.2% | 1,498,100 | 0.0% | 0.29% | -24.5% | |
| SRL | Sell | SCULLY ROYALTY LTD | $9,348,000 | -4.1% | 753,885 | -9.9% | 0.29% | -20.2% |
| FTACU | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $9,107,000 | +1.2% | 842,730 | 0.0% | 0.28% | -15.9% | |
| RFL | RAFAEL HLDGS INC | $8,659,000 | -14.9% | 485,366 | 0.0% | 0.27% | -29.2% | |
| SIGA | Sell | SIGA TECHNOLOGIES INC | $8,399,000 | -8.9% | 1,760,764 | -2.2% | 0.26% | -24.3% |
| IGT | INTERNATIONAL GAME TECHNOLOGcall | $7,485,000 | +5.3% | 500,000 | 0.0% | 0.23% | -12.2% | |
| CBIO | Buy | CATALYST BIOSCIENCES INC | $7,299,000 | +39.9% | 1,071,749 | +0.8% | 0.22% | +16.6% |
| LINC | LINCOLN EDL SVCS CORP | $7,067,000 | +39.4% | 2,436,805 | 0.0% | 0.22% | +16.0% | |
| NEOS | NEOS THERAPEUTICS INC | $6,961,000 | +2.0% | 4,610,000 | 0.0% | 0.21% | -15.4% | |
| AFI | Sell | ARMSTRONG FLOORING INC | $6,534,000 | -37.6% | 1,530,105 | -6.6% | 0.20% | -48.2% |
| SSKN | STRATA SKIN SCIENCES INC | $6,058,000 | -1.2% | 2,851,001 | 0.0% | 0.19% | -17.6% | |
| TA | TRAVELCENTERS OF AMERICA INC | $5,786,000 | +39.2% | 337,390 | 0.0% | 0.18% | +15.6% | |
| CEMI | CHEMBIO DIAGNOSTICS INC | $5,654,000 | -25.5% | 1,239,983 | 0.0% | 0.17% | -38.1% | |
| ZVO | Buy | ZOVIO INC | $5,465,000 | +156.0% | 2,653,087 | +144.8% | 0.17% | +112.7% |
| INSUU | INSURANCE ACQUISITION CORPunit 03/31/2024 | $5,320,000 | +2.1% | 500,000 | 0.0% | 0.16% | -15.0% | |
| NATR | Buy | NATURES SUNSHINE PRODUCTS IN | $5,334,000 | +10.3% | 597,310 | +2.4% | 0.16% | -8.4% |
| APEN | APOLLO ENDOSURGERY INC | $5,278,000 | -11.4% | 1,810,562 | 0.0% | 0.16% | -26.2% | |
| ARYAU | ARYA SCIENCES ACQUISITION COunit 10/04/2023 | $5,209,000 | +4.9% | 452,944 | 0.0% | 0.16% | -13.0% | |
| XELA | EXELA TECHNOLOGIES INC | $5,210,000 | -65.4% | 12,777,887 | 0.0% | 0.16% | -71.4% | |
| GLMD | GALMED PHARMACEUTICALS LTD | $5,082,000 | +20.9% | 879,200 | 0.0% | 0.16% | +0.6% | |
| ACER | ACER THERAPEUTICS INC | $3,973,000 | +25.7% | 990,655 | 0.0% | 0.12% | +4.3% | |
| STRM | Buy | STREAMLINE HEALTH SOLUTIONS | $3,828,000 | +100.5% | 2,753,599 | +56.4% | 0.12% | +66.2% |
| RH | Sell | RH | $3,799,000 | -94.1% | 17,793 | -95.3% | 0.12% | -95.1% |
| HTGM | HTG MOLECULAR DIAGNOSTICS IN | $3,510,000 | +5.6% | 5,000,000 | 0.0% | 0.11% | -12.2% | |
| EVRI | New | EVERI HLDGS INC | $3,358,000 | – | 250,000 | +100.0% | 0.10% | – |
| EMMS | EMMIS COMMUNICATIONS CORP | $3,151,000 | -19.6% | 781,783 | 0.0% | 0.10% | -33.1% | |
| DVD | DOVER MOTORSPORTS INC | $3,154,000 | -6.0% | 1,695,541 | 0.0% | 0.10% | -21.8% | |
| SNSS | Buy | SUNESIS PHARMACEUTICALS INC | $2,960,000 | -46.6% | 8,765,600 | +13.8% | 0.09% | -55.6% |
| TFFP | New | TFF PHARMACEUTICALS INC | $2,809,000 | – | 525,000 | +100.0% | 0.09% | – |
| MACK | MERRIMACK PHARMACEUTICALS IN | $2,355,000 | -30.0% | 747,635 | 0.0% | 0.07% | -41.6% | |
| ELVT | Sell | ELEVATE CREDIT INC | $2,150,000 | -67.4% | 483,068 | -69.2% | 0.07% | -73.1% |
| New | DARIOHEALTH CORP | $1,404,000 | – | 214,091 | +100.0% | 0.04% | – | |
| FALCON MINERALS CORP*w exp 07/21/202 | $1,177,000 | +24.9% | 878,022 | 0.0% | 0.04% | +2.9% | ||
| FBIO | Buy | FORTRESS BIOTECH INC | $1,047,000 | +120.4% | 407,208 | +21.0% | 0.03% | +77.8% |
| PHGEU | New | BIOMX INCunit 10/16/2024 | $952,000 | – | 100,000 | +100.0% | 0.03% | – |
| MOTS | MOTUS GI HLDGS INC | $957,000 | +15.7% | 417,708 | 0.0% | 0.03% | -6.5% | |
| CVNA | Sell | CARVANA COcl a | $55,000 | -95.5% | 595 | -96.8% | 0.00% | -95.6% |
| CHAC | Exit | CHARDAN HEALTHCARE ACQUISITI | $0 | – | -100,000 | -100.0% | -0.04% | – |
| DRIO | Exit | DARIOHEALTH CORP | $0 | – | -4,281,652 | -100.0% | -0.05% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -38,247 | -100.0% | -0.05% | – |
| RMBL | Exit | RUMBLEON INCcl b | $0 | – | -1,634,350 | -100.0% | -0.18% | – |
| PRTY | Exit | PARTY CITY HOLDCO INCcall | $0 | – | -1,000,000 | -100.0% | -0.21% | – |
| SHOS | Exit | SEARS HOMETOWN & OUTLET STOR | $0 | – | -2,131,251 | -100.0% | -0.28% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INCcall | $0 | – | -2,000,000 | -100.0% | -0.29% | – |
| AGS | Exit | PLAYAGS INC | $0 | – | -900,000 | -100.0% | -0.34% | – |
| RDNT | Exit | RADNET INC | $0 | – | -1,129,814 | -100.0% | -0.60% | – |
| CURO | Exit | CURO GROUP HLDGS CORP | $0 | – | -1,229,332 | -100.0% | -0.60% | – |
| AABA | Exit | ALTABA INC | $0 | – | -883,464 | -100.0% | -0.64% | – |
| QQQ | Exit | INVESCO QQQ TRput | $0 | – | -550,000 | -100.0% | -3.85% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-02-14
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ISHARES TR | 42 | Q3 2023 | 27.2% |
| CODEXIS INC | 42 | Q3 2023 | 3.9% |
| PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
| SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
| DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
| GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
| QAD INC | 32 | Q3 2021 | 2.6% |
| SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
| DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
| LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
| Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
| AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
| ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
| Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
| Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
| Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
| CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
| Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-21 |
| 4 | 2024-03-15 |
| SC 13G | 2024-03-11 |
| 13F-HR/A | 2024-02-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.